Procurement Summary
Country: Canada
Summary: Develop Canadian Drug Data Catalogue (Cddc) Phase 1
Deadline: 12 Jun 2025
Posting Date: 02 May 2025
Other Information
Notice Type: Tender
TOT Ref.No.: 118522630
Document Ref. No.: C-242505560
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
An overview of our requirements is outlined below. For more information and Proposal submission instructions, refer to the RFP main document. CDA-AMC is undertaking foundational work to support the future development of a Canadian Drug Data Catalogue ("Catalogue")—a web-based, publicly accessible resource designed to improve discovery and understanding of drug data assets across Canada. The Catalogue will serve as a top-layer navigational tool that links to existing data discovery platforms, helping users locate, compare, and assess key drug-related datasets through standardized metadata. Thework outlined in this contract includes two components:Part A: Drug Data Asset Inventory: A comprehensive scan and documentation of drug data stewards and datasets across Canada—public, private and pan-Canadian —highlighting their characteristics, accessibility, governance, and linkability.Part B: Best Practices in Data Cataloguing and Metadata Frameworks: An evidence-based review of national and international approaches to metadata cataloguing, with stakeholder engagement to define metadata standards and inform the Catalogue's structure and interoperability requirements.
Solicitation Type : RFP - Request for Proposal (Formal)
Reference Number : 0000288196
Location : Canada, Ontario, Ottawa
Delivery Point 600-865 Carling Ave Ottawa, Ontario Canada K1S 5S8
Purchase Type : One Time Only- Delivery Date:2026/02/20
Description : An overview of our requirements is outlined below. For more information and Proposal submission instructions, refer to the RFP main document. CDA-AMC is undertaking foundational work to support the future development of a Canadian Drug Data Catalogue ("Catalogue")—a web-based, publicly accessible resource designed to improve discovery andunderstanding of drug data assets across Canada. The Catalogue will serve as a top-layer navigational tool that links to existing data discovery platforms, helping users locate, compare, and assess key drug-related datasets through standardized metadata. The work outlined in this contract includestwo components:Part A: Drug Data Asset Inventory: A comprehensive scan and documentation of drug data stewards and datasets across Canada—public, private and pan-Canadian —highlighting their characteristics, accessibility, governance, and linkability.Part B: Best Practices in Data Cataloguing and Metadata Frameworks: An evidence-based review of national and international approaches to metadata cataloguing, with stakeholder engagement to define metadata standards and inform the Catalogue's structure and interoperability requirements.
Documents
Tender Notice